Eunyoung Cho

About

Dr. Eunyoung Cho is an Associate Professor and Director of Research in the Department of Dermatology at the Warren Alpert Medical School of Brown University. She also holds an appointment as an Associate Professor in the Department of Epidemiology at Brown School of Public Health. Her academic background includes a BS and MS in Food Science and Nutrition from Seoul National University, and a ScD in Nutrition and Epidemiology from Harvard School of Public Health. She was a Predoctoral and Postdoctoral Fellow in the Department of Nutrition at Harvard. After serving Harvard Medical School for 12 years as a faculty member, she joined Brown University in 2014. Her primary research interest is evaluating the role of diet and nutrition in the development of chronic diseases using epidemiologic approaches. She has led several projects on diet and chronic diseases, including age-related macular degeneration, various cancers, and dermatological disorders such as skin cancer, alopecia areata, psoriasis, atopic dermatitis, and rosacea. Dr. Cho has been funded by prominent organizations including the US NIH, American Institute for Cancer Research, Harvard University, Kidney Cancer Association, and Dana-Farber Cancer Institute. She has served as a grant reviewer for multiple agencies and foundations, and received the SUN Pharma-Society for Investigative Dermatology Mid-Career Investigator Award in 2021. Additionally, she serves as an Associate Editor for Cancer Causes and Control and is…

Research topics

• Medicine
• Internal medicine
• Oncology
• Environmental health
• Dermatology
• Pharmacology

Selected publications

• Tea Consumption and Risk of Cancer: An Umbrella Review and Meta-Analysis of Observational Studies

  Advances in Nutrition · 2020 · 125 citations

  DOI

• Photosensitizing Medications and Skin Cancer: A Comprehensive Review

  Cancers · 2021 · 28 citations

  Senior authorCorresponding

  (1) The incidence of skin cancer is increasing in the United States (US) despite scientific advances in our understanding of skin cancer risk factors and treatments. In vitro and in vivo studies have provided evidence that suggests that certain photosensitizing medications (PSMs) increase skin cancer risk. This review summarizes current epidemiological evidence on the association between common PSMs and skin cancer. (2) A comprehensive literature search was conducted to identify meta-analyses, o…

  DOI

• Consumption of Red Versus White Wine and Cancer Risk: A Meta-Analysis of Observational Studies

  Nutrients · 2025-01-31 · 10 citations

  reviewOpen accessSenior authorCorresponding

  Background/Objectives: While alcoholic beverage consumption increases cancer risk, red wine has been touted as a healthier option. To address this unexplored question, we conducted a meta-analysis to summarize evidence from observational studies. Methods: A literature search of PubMed and EMBASE through December 2023 identified studies examining wine and cancer risk. A random-effects meta-analysis was performed to estimate relative risks (RRs) and 95% confidence intervals (CIs) for an associatio…

  PublisherOA PDFDOI

• Selenium exposure and risk of skin cancer: A systematic review and dose-response meta-analysis of epidemiologic evidence

  Journal of Trace Elements in Medicine and Biology · 2025-07-07 · 3 citations

  reviewOpen access

  BACKGROUND: Controversies still exist about the effects of selenium exposure on skin cancer risk. METHODS: We performed a systematic literature search of non-experimental and experimental studies investigating the relation between selenium and risk of melanoma and non-melanoma skin cancers (NMSC) in adults. RESULTS: We identified 26 studies, 19 of which were suitable for quantitative meta-analysis. In non-experimental studies, serum/plasma selenium concentrations showed slightly lower risk of NM…

  PublisherDOI

• Oral and topical vitamin D treatment strategies in psoriasis

  Skin Health and Disease · 2025-04-22 · 2 citations

  reviewOpen accessSenior author

  Psoriasis is a prevalent skin disorder affecting approximately 2-3% of the population in the USA. Its complex and varied presentations necessitate a diverse range of available therapeutic options. While topical corticosteroid therapy is conventionally employed as first-line treatment, long-term usage increases the risk of adverse events, prompting the consideration of alternatives including steroid-sparing agents such as vitamin D. In this article, we review literature from topical and oral vita…

  PublisherDOI

Recent grants

• NIH Grant R03CA108341

  NIH · $173k · 2006

• NIH Grant R03CA125763

  NIH · $175k · 2010

• Psoralens and melanoma

  NIH · $432k · 2015–2018

Frequent coauthors

• Abrar A. Qureshi

  Providence College

  1452 shared

• Wenqing Li

  534 shared

• Edward L. Giovannucci

  Harvard University

  509 shared

• Walter C. Willett

  Brigham and Women's Hospital

  445 shared

• Charles S. Fuchs

  353 shared

• Xuehong Zhang

  Harvard University

  288 shared

• Aaron M. Drucker

  University of Toronto

  285 shared

• Donna Spiegelman

  Yale University

  274 shared

Education

• B.S., Food Science and Nutrition

  Seoul National University

• M.S., Food Science and Nutrition

  Seoul National University

• Other, Nutrition and Epidemiology

  Harvard School of Public Health

Awards & honors

• SUN Pharma-Society for Investigative Dermatology (SID) Mid-C…

Similar researchers at Brown University

• Kenneth Mayerh-156
• Jennifer Friedmanh-102
• Dwight Rouseh-97